Quality of End-of-Life Care for Children With Cancer
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- Children's Oncology Group
- Study ID
- NCT07412002
- Status
- Recruiting
Conditions
- Childhood Hematopoietic and Lymphatic System Neoplasm
- Childhood Malignant Solid Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study examines the role of access to care, patient/family interactions with the healthcare system, and stress in explaining variations in quality of end of life care. The data collected from this study may help researchers develop a model for identifying patients at risk of low quality end of life care as well as recommendations for potential future interventions.
Key Dates
- Start date
- Jun 15, 2026
- Status verified
- Jun 2026
- Primary completion
- Jan 31, 2031
- Completion
- Jan 31, 2031
Study Design
- Enrollment
- 1,190 participants (estimated)
Arms
- Arm: Observational part 1The medical records of deceased patients are reviewed on study.
- Arm: Observational part 2Bereaved parents complete a survey and may participate in an interview on study.
Primary Outcome Measure
Quality of end of life (EOL) care [ Time Frame: Up to study completion, an average of 4 years ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital of Pittsburgh of UPMC | Pittsburgh | Pennsylvania | 15224 | Jean M. Tersak (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Pittsburgh, PA
By research site
Related Studies
- An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid TumorsPHASE3 · Recruiting · Mayo Clinic · Rochester, Minnesota